Correlation Between Vertex Pharmaceuticals and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Bristol Myers Squibb, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Bristol Myers.
Diversification Opportunities for Vertex Pharmaceuticals and Bristol Myers
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Vertex and Bristol is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Bristol Myers go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Bristol Myers
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 1.15 times more return on investment than Bristol Myers. However, Vertex Pharmaceuticals is 1.15 times more volatile than Bristol Myers Squibb. It trades about 0.07 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.09 per unit of risk. If you would invest 28,789 in Vertex Pharmaceuticals on January 30, 2024 and sell it today you would earn a total of 10,991 from holding Vertex Pharmaceuticals or generate 38.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Vertex Pharmaceuticals vs. Bristol Myers Squibb
Performance |
Timeline |
Vertex Pharmaceuticals |
Bristol Myers Squibb |
Vertex Pharmaceuticals and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vertex Pharmaceuticals and Bristol Myers
The main advantage of trading using opposite Vertex Pharmaceuticals and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Bristol Myers vs. Johnson Johnson | Bristol Myers vs. Amgen Inc | Bristol Myers vs. Fidelity Freedom Blend | Bristol Myers vs. Income Fund Of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |